The Calmer Co. Secures Coles Ranging for Fiji Kava FZZR and Pushes U.S. Retail Expansion
The Calmer Co. has won Coles' approval for its innovative Fiji Kava® FZZR™ product, extending its Australian supermarket reach while gearing up for a broader U.S. retail rollout supported by a key brokerage partnership.
- Coles accepts new Fiji Kava® FZZR™ product for October 2026 launch
- FZZR™ format offers versatile consumption and flavour innovation under TGA regulation
- Fiji Kava® powders rank No.1 and No.3 in Coles national Stress category
- Company holds estimated 10% share of U.S. Amazon kava market
- Appointment of VDriven to drive U.S. retail channel expansion
Coles Backs Fiji Kava® FZZR™ for Australian Supermarkets
The Calmer Co. International Limited (ASX:CCO) has secured a significant retail win with Coles confirming the ranging of its new Fiji Kava® FZZR™ product in the latest range review, targeting an October 2026 rollout. This follows the company's established presence in Woolworths, collectively covering about 67% of Australia's grocery retail footprint.
The FZZR™ format is a proprietary innovation combining powders and effervescent granules, enabling consumers to drink it as a sparkling beverage, chew it, or consume it direct-to-mouth. This versatility, along with flavour innovations like Piña Colada, is made possible under the Therapeutic Goods Administration's complementary medicine pathway, allowing standardised kava water extracts that traditional food regulations do not permit.
Strong Category Performance and Consumer Acceptance
The Fiji Kava® 150g and 50g instant powder products currently hold the No.1 and No.3 positions respectively in Coles’ national Stress category, underscoring growing consumer acceptance of kava-based wellness products in mainstream Australian retail. The Calmer Co. sees the FZZR™ format as a strategic extension to attract new consumers through enhanced convenience, portability, and flavour accessibility.
Having demonstrated scalability within Australia’s two largest supermarket chains, the company views these achievements as a blueprint for international growth.
Building on U.S. Amazon Success to Expand Physical Retail
On the international front, The Calmer Co. estimates it commands approximately 10% of the U.S. Amazon kava sales market, a foothold it plans to leverage for expansion into physical retail channels. To accelerate this, the company has appointed VDriven, a leading U.S. natural products brokerage, to support distribution across natural, organic, and specialty retail outlets.
Industry data cited by the company indicates that over 10% of U.S. adults surveyed have consumed kava in the past year, signalling growing consumer awareness and potential for category expansion. The FZZR™ format’s portability and non-traditional delivery align well with evolving U.S. wellness trends.
Innovation and Regulation as Growth Drivers
The TGA complementary medicine pathway not only enables the use of standardised kava extracts but also supports flavour innovation, setting the Fiji Kava® brand apart in both Australian and potentially international markets. This regulatory clarity is crucial, given the limitations under existing food regulations for kava products.
Founder and CEO Zane Yoshida emphasised the strategic importance of these developments, highlighting the FZZR™ technology’s role in broadening category accessibility and the company's readiness to scale both domestically and abroad.
Bottom Line?
The Calmer Co.’s innovative product format and dual-market strategy position it well for growth, but execution in U.S. retail channels and consumer uptake of FZZR™ will be critical to watch.
Questions in the middle?
- How will consumers respond to the novel FZZR™ consumption format and Piña Colada flavour?
- What commercial terms and rollout scale will The Calmer Co. achieve with Coles and U.S. retailers?
- Can the company convert its Amazon U.S. market share into sustained physical retail presence?
